Join the SDP Boston Chapter for an engaging online discussion featuring Charles Persinger and Jay Andersen, who will share key insights from their extensive work in decision sciences and portfolio management at Eli Lilly. Discover how quantitative probability assessments have shaped 26 years of portfolio decisions, improving technical feasibility evaluations and investment strategies in pharmaceutical R&D.
Read more about this topic on LinkedIn: Probability Assessments at Eli Lilly
This session will explore:
- Structured decision processes for R&D portfolio management
- Mitigating biases in probability assessment
- Performance calibration for informed investment decisions
Don't miss this opportunity to gain practical takeaways for professionals in drug development, strategy, and risk management!
Click here to Register
------------------------------
SDP Boston Chapter
------------------------------